Posted in | News

ProLogis Receives Two Construction Projects in France and Japan

ProLogis (NYSE: PLD), a leading global provider of distribution facilities, announced today it has signed two build-to-suit agreements, totaling approximately 522,000 square feet (48,500 square meters). These transactions will be second-quarter development starts and represent approximately $60 million of total expected investment.

Including previously announced development transactions, these transactions bring ProLogis' year-to-date 2010 global development starts to approximately $437 million of total expected investment with approximately $133 million of ProLogis land. Combined with year-to-date third-party sales of approximately $47 million, ProLogis has monetized $180 million of land. The company has established goals of $700 to $800 million of global development starts and $350 to $400 million of land monetization during 2010.

The build-to-suit projects include agreements in:

  • Moissy-Cramayel, France, where the company will construct a 342,000-square-foot (31,800-square-meter) distribution facility for a major third-party logistics company on ProLogis-owned land at ProLogis Park Chanteloup, located approximately 18 miles (30 kilometers) south of Paris near the A5, A4 and A6 motorways.
  • Northern Japan, where ProLogis will construct a 180,000-square-foot (16,700-square-meter) distribution facility for one of Japan's leading retailers on ProLogis-owned land. After completion, the development will be sold to the customer at a pre-committed value.

ProLogis has a proven track record for best-in-class industrial development and the ability to meet its customers' specific industrial development needs throughout North America, Europe and Asia. As of December 31, 2009, the company has developed more than 300 million square feet (27 million square meters) of ProLogis-owned and managed facilities.

Source: http://www.prologis.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.